Glycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson's Disease

被引:0
|
作者
Chatterjee, Sayan [1 ,2 ]
Verma, Arvind [3 ]
Thakkar, Harsh [3 ,4 ]
Shah, Ravi P. [3 ]
Khairnar, Amit [1 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Inst Pharmaceut Educ & Res Ahmedabad NIPER A, Dept Pharmacol & Toxicol, Ahmadabad 382355, Gujarat, India
[2] Parul Univ, Parul Inst Pharm & Res, Dept Pharmacol, Vadodara 391760, Gujarat, India
[3] Natl Inst Pharmaceut Educ & Res Ahmedabad NIPER A, Dept Pharmaceut Anal, Ahmadabad 382355, Gujarat, India
[4] Scripps Res Inst, Neurosci Dept, La Jolla, CA 92037 USA
[5] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno 60200, Czech Republic
[6] Masaryk Univ, Fac Med, Int Clin Res Ctr, Brno 62500, Czech Republic
[7] ICRC, FNUSA, Brno 65691, Czech Republic
[8] Masaryk Univ, Fac Med, Dept Physiol, Brno 62500, Czech Republic
关键词
ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ENDPRODUCTS; RAGE; CONFORMATION; PATHOGENESIS; AGGREGATION; EXPRESSION; OLIGOMERS; TOXICITY;
D O I
10.1021/acschembio.4c00777
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of misfolded alpha-synuclein (alpha-Syn) leads to the formation of Lewy bodies and is a major hallmark of Parkinson's disease (PD). The accumulation of alpha-Syn involves several post-translational modifications. Recently, though, glycation of alpha-Syn (advanced glycation end products) and activation of the receptor for advanced glycation end products (RAGE) have been linked to neuroinflammation, which leads to oxidative stress and accumulation of alpha-Syn. The present study aims to detect the effect of glycated alpha-Syn (gly-alpha-Syn)-induced synucleinopathy and loss of dopaminergic (DAergic) neurons in the development of PD. We isolated, purified, and prepared glycated recombinant human alpha-Syn using d-ribose. Gly-alpha-Syn was characterized by SDS-PAGE, intact mass analysis, and bottom-up peptide sequence through LC-HRMS/MS. The aggregation propensity of gly-alpha-Syn has been verified by morphological and shape analysis through Bio-AFM. The gly-alpha-Syn (2 mu g/mu L) was injected stereotaxically in the substantia nigra (SN) of ICR mice (3-4 months) and compared with the normal alpha-Syn, d ribose, and Tris-HCl/artificial CSF groups. 56 days postsurgery (DPS), an immunohistochemical examination was conducted to investigate gly-alpha-Syn-induced alpha-Syn accumulation, neuroinflammation, and neurodegeneration. The glycation of alpha-Syn led to the expression of transglutaminase 2 (TGM2), an enzyme that cross-linked with AGEs and may have caused the accumulation of alpha-Syn. Significant RAGE activation was also observed in gly-alpha-Syn, which might have induced glial cell activation, resulting in oxidative stress and, ultimately, apoptosis of dopaminergic neurons. It is important to note that TGM2, phosphorylated alpha-Syn, RAGE expression, and glial cell activation were only found in the gly-alpha-Syn group and not in the other groups. This suggests that gly-alpha-Syn plays a major role in synucleinopathy, neuroinflammation, and neurodegeneration. Overall, the present study demonstrated glycation of alpha-Syn as one of the important age-associated post-translational modifications that are involved in the degeneration of dopaminergic neurons, at least in a subset of the diabetic patients susceptible to developing PD.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson's disease
    Bao-Yan Wang
    Yong-Yi Ye
    Chen Qian
    Hong-Bo Zhang
    Heng-Xu Mao
    Long-Ping Yao
    Xiang Sun
    Guo-Hui Lu
    Shi-Zhong Zhang
    Neural Regeneration Research, 2021, 16 (12) : 2521 - 2527
  • [22] Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease
    Chung, Young C.
    Baek, Jeong Y.
    Kim, Sang R.
    Ko, Hyuk W.
    Bok, Eugene
    Shin, Won-Ho
    Won, So-Yoon
    Jin, Byung K.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2017, 49 : e298 - e298
  • [23] Effect of electroacupuncture on dopaminergic neurons in a rat model of Parkinson's disease based on the α-synuclein pathway
    Chen, Liudan
    Chen, Ke
    Ai, Liang
    Cao, Linhui
    Zhang, Bin
    Li, Xue
    Kang, Mengru
    Li, Jianjun
    MATERIALS EXPRESS, 2020, 10 (01) : 62 - 69
  • [24] Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson’s disease
    Young C Chung
    Jeong Y Baek
    Sang R Kim
    Hyuk W Ko
    Eugene Bok
    Won-Ho Shin
    So-Yoon Won
    Byung K Jin
    Experimental & Molecular Medicine, 2017, 49 : e298 - e298
  • [25] Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson’s disease
    Irmgard Paris
    Sergio Cardenas
    Jorge Lozano
    Carolina Perez-Pastene
    Rebecca Graumann
    Alejandra Riveros
    Pablo Caviedes
    Juan Segura-Aguilar
    Neurotoxicity Research, 2007, 12 : 125 - 134
  • [26] Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease
    Gao, HM
    Jiang, J
    Wilson, B
    Zhang, W
    Hong, JS
    Liu, B
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 (06) : 1285 - 1297
  • [27] Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease
    Paris, Irmgard
    Cardenas, Sergio
    Lozano, Jorge
    Perez-Pastene, Carolina
    Graumann, Rebecca
    Riveros, Alejandra
    Caviedes, Pablo
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2007, 12 (02) : 125 - 134
  • [28] Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson's Disease
    Yong, Yuxuan
    Wu, Qinfen
    Meng, Xinling
    Lu, Ranran
    Xia, Huan
    Pei, Feifei
    Yang, Xinling
    PARKINSONS DISEASE, 2023, 2023
  • [29] Participation of Par-4 in degeneration of dopaminergic neurons in models of Parkinson's disease
    Duan, W
    Gash, DM
    Rangnekar, VM
    Mattson, MP
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 : S20 - S20
  • [30] Somatic cell reprogramming into dopaminergic neurons for Parkinson's disease therapy
    Broccoli, V.
    Caiazzo, M.
    Anno, M. T. Dell'
    Leo, D.
    Gainetdinov, R.
    Pezzoli, G.
    Dityatev, A.
    JOURNAL OF NEUROLOGY, 2012, 259 : S5 - S6